Rethinking Our Approach to Canine Osteoarthritis
- Share via
Key Facts
- Osteoarthritis (OA) is a leading cause of chronic pain and mobility loss in older dogs.
- Management is “multimodal,” combining pharmaceuticals, weight control, and physical therapy.
- Non-steroidal anti-inflammatory drugs (NSAIDs) are a cornerstone of pain management.
- Weight loss is one of the most effective non-pharmaceutical interventions for improving mobility.
- New guidelines (COASTeR) help clinicians match treatments to the specific stage of a dog’s OA.
The Old Dog Dilemma
You see it on the schedule and you already know. “Old dog, limping.” The owner says he’s just “getting old,” but that’s a common euphemism for “he hurts.” And the diagnosis is pretty much a given: osteoarthritis. OA. It’s the slow, grinding destruction of a joint [6]. The cartilage wears thin, the lubricating fluid breaks down, and painful inflammation sets in. It’s a one-way street, a chronic disease with no finish line. So, what’s the play? For decades, the answer was easy: grab a bottle of NSAIDs.
And let’s be clear, non-steroidal anti-inflammatories—your carprofens, your meloxicams—are the cornerstone of OA management for a reason [2] [5]. They flat-out work. They knock down pain and inflammation, and the data backing them up is a mile high [9]. For so many dogs, these drugs are nothing short of a miracle. They turn a dog who can barely stand up into one who’s meeting you at the door again. Simple. Powerful.
Except it’s never that simple, is it? We’re talking about senior dogs. Dogs who show up with a whole case file of other issues. Kidneys that are working a little too hard. A finicky stomach. And that little voice in the back of our heads starts whispering about the risks of long-term NSAID use. What do you do for the dog who can’t take them? Or for the owner who is, quite rightly, worried about piling yet another medication onto their dog’s daily regimen? This is where the simple, easy answer just crumbles.
Suddenly our toolkit is overflowing. Piprant antagonists. Monoclonal antibodies that target pain pathways in a whole new way [9]. Add-on drugs like gabapentin for when the pain signals get scrambled and weird [12]. The options are fantastic, but they create their own kind of paralysis. It’s easy to get lost, chasing symptoms with a cocktail of drugs instead of a real strategy. We’ve gone from writing a simple prescription to trying to solve a complex puzzle [12]. And the most important pieces of that puzzle aren’t even in the pharmacy.
Beyond the Medication
This is the part of the talk that’s less about a prescription pad and more about a life change. The part that requires real work. The most powerful, evidence-backed tool we have for fighting OA isn’t a laser or a needle. It’s getting the weight off [1]. Full stop.
Taking that extra load off a pair of creaky hips can do more for a dog’s comfort than half the drugs we prescribe. Shaving just a few pounds off an overweight dog can make a shocking difference in how they move. But man, is it a tough conversation. It means the owner has to completely change how they show love—no more pizza crusts, no more “just a little piece.” It’s a daily commitment. It’s a grind.
And then there’s physical therapy. The old advice was to “let him rest.” We couldn’t have been more wrong. We now know that wasting muscle is the surest way to destabilize a painful joint [3]. The motto is motion is lotion. Controlled, low-impact exercise is king. This is where things like underwater treadmills are worth their weight in gold. The water takes the weight off, letting the dog build back the muscle that supports those failing joints [3]. Simple exercises at home can keep things from seizing up. It’s about fighting back, not giving in.
We also can’t forget the ridiculously simple things. The home game. Throwing down some cheap rubber-backed runners on slippery hardwood floors. Getting a ramp for the car. Buying a good orthopedic bed that they don’t have to haul themselves out of like it’s quicksand. These things aren’t a cure. But they make everything else we do work ten times better. This is the foundation. Without it, all the pills in the world are just papering over the cracks.
Sorting Through the Noise
And then you open the door to the world of supplements and “alternatives,” and the noise is deafening. Every client has a cousin whose neighbor’s dog was cured by this one powder. Green-lipped mussel [5]. Elk velvet antler [10]. The list goes on forever. Some of them, like green-lipped mussel, actually have some decent science behind them suggesting they can help with inflammation [1]. But many others? The data is flimsy, anecdotal, or just plain absent. It’s a minefield of slick marketing and heartfelt testimonials.
Then you have things like acupuncture, which has gained a lot of respect and has some solid evidence, especially for dogs that can’t handle the heavy-hitting drugs [10]. PRP injections, using the body’s own platelets to cool off an inflamed joint, show real promise in some cases, too [11]. But the results can be all over the map. It’s not the Wild West anymore, but let’s just say the territory isn’t fully mapped. Our job is to figure out what’s plausible and what’s just hope in a bottle.
This is where we, as a field, are trying to get a lot smarter. An owner wants to see improvement, so they often do. Proving it is another story. That’s why there’s a push for objective data, like using force plates to see if a dog is actually putting more weight on a sore leg [4]. It’s the gold standard for cutting through the placebo effect. But since most clinics don’t have that tech, we have to blend it with owner surveys and activity monitors to get the real story [4].
We’re also finally getting better roadmaps. Guidelines like COASTeR give us a logical way to match the treatment to the stage of the disease [8]. This is a massive step up from just trying things until something works. At the same time, researchers are looking at entirely new ways to tackle the problem, like sEHI drugs that target inflammation from a new angle [7].
In the end, though, it always comes back to that one dog, in that one exam room. There’s no flowchart, no single right answer. Managing OA means being a good mechanic and a better listener. It’s about combining the heavy hitters like drugs and weight loss with the nuance of physical therapy and a healthy skepticism of the latest fad. It means checking in, over and over, because what works today might not work in six months.
Because the goal isn’t some miracle cure. It’s simpler than that. It’s about giving an old friend a comfortable, engaged life instead of one spent watching from the sidelines. And that’s a puzzle worth our time, every time.
References
[1] Pye, C., Clark, N., Bruniges, N., Peffers, M., & Comerford, E. (2024). Current evidence for non-pharmaceutical, non-surgical treatments of canine osteoarthritis. The Journal of small animal practice, 65(1), 3–23. https://doi.org/10.1111/jsap.13670
[2] Sanderson, R. O., Beata, C., Flipo, R. M., Genevois, J. P., Macias, C., Tacke, S., Vezzoni, A., & Innes, J. F. (2009). Systematic review of the management of canine osteoarthritis. The Veterinary record, 164(14), 418–424. https://doi.org/10.1136/vr.164.14.418
[3] Mille, M. A., McClement, J., & Lauer, S. (2022). Physiotherapeutic Strategies and Their Current Evidence for Canine Osteoarthritis. Veterinary sciences, 10(1), 2. https://doi.org/10.3390/vetsci10010002
[4] Rialland, P., Bichot, S., Moreau, M., Guillot, M., Lussier, B., Gauvin, D., Martel-Pelletier, J., Pelletier, J. P., & Troncy, E. (2012). Clinical validity of outcome pain measures in naturally occurring canine osteoarthritis. BMC veterinary research, 8, 162. https://doi.org/10.1186/1746-6148-8-162
[5] Henrotin, Y., Sanchez, C., & Balligand, M. (2005). Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. Veterinary journal (London, England : 1997), 170(1), 113–123. https://doi.org/10.1016/j.tvjl.2004.08.014
[6] Rychel J. K. (2010). Diagnosis and treatment of osteoarthritis. Topics in companion animal medicine, 25(1), 20–25. https://doi.org/10.1053/j.tcam.2009.10.005
[7] McReynolds, C. B., Hwang, S. H., Yang, J., Wan, D., Wagner, K., Morisseau, C., Li, D., Schmidt, W. K., & Hammock, B. D. (2019). Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis. Frontiers in pharmacology, 10, 533. https://doi.org/10.3389/fphar.2019.00533
[8] Cachon, T., Frykman, O., Innes, J. F., Lascelles, B. D. X., Okumura, M., Sousa, P., Staffieri, F., Steagall, P. V., & Van Ryssen, B. (2023). COAST Development Group’s international consensus guidelines for the treatment of canine osteoarthritis. Frontiers in veterinary science, 10, 1137888. https://doi.org/10.3389/fvets.2023.1137888
[9] Pye, C., Bruniges, N., Peffers, M., & Comerford, E. (2022). Advances in the pharmaceutical treatment options for canine osteoarthritis. The Journal of small animal practice, 63(10), 721–738. https://doi.org/10.1111/jsap.13495
[10] Miscioscia, E., & Repac, J. (2022). Evidence-Based Complementary and Alternative Canine Orthopedic Medicine. The Veterinary clinics of North America. Small animal practice, 52(4), 925–938. https://doi.org/10.1016/j.cvsm.2022.02.003
[11] Alves, J. C. A., Santos, A. M. M. P. D., Jorge, P. I. F., Lavrador, C. F. T. V. B., & Carreira, L. M. A. (2021). Management of Osteoarthritis Using 1 Intra-articular Platelet Concentrate Administration in a Canine Osteoarthritis Model. The American journal of sports medicine, 49(3), 599–608. https://doi.org/10.1177/0363546520981558
[12] Diehm, M., & Tünsmeyer, J. (2018). Multimodale Therapie der kaninen Osteoarthritis – aktueller Stand und neue Optionen [Update of multimodal therapy in canine osteoarthritis]. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere, 46(5), 337–345. https://doi.org/10.15654/TPK-180690
